CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Modified FOLFIRI as Second-Line Chemotherapy after Failure of Modified FOLFOX-4 in Advanced Gastric Cancer
Eun Kyoung Jeon, Sook Hee Hong, Tae Hee Kim, Seung Eun Jung, Ji Chan Park, Hye-Sung Won, Yoon-Ho Ko, Sang Young Rho, Young Seon Hong
Cancer Research and Treatment. 2011;43(3):148-153.   Published online 2011 September 30    DOI: https://doi.org/10.4143/crt.2011.43.3.148

Excel Download

Modified FOLFIRI as Second-Line Chemotherapy after Failure of Modified FOLFOX-4 in Advanced Gastric Cancer
Cancer Research and Treatment. 2011;43(3):148-153   Crossref logo
Link1 Link2

Su1959 Efficacy and Safety of FOLFIRI After Failure of FOLFOX-4 in Advanced Gastric Cancer
Gastroenterology. 2013;144(5):S-519   Crossref logo
Link1 Link2

A randomized trial of FOLFIRI versus docetaxel and cisplatin as a second-line chemotherapy after failure of first-line chemotherapy in advanced gastric cancer
Annals of Oncology. 2017;28:iii34   Crossref logo
Link1 Link2 Link3

P-0025 Modified Folfiri (mFolfiri) as Second Line Chemotherapy in Advanced Gastric Cancer (AGC)
Annals of Oncology. 2012;23:iv38   Crossref logo
Link1 Link2

Efficacy and Safety of FOLFIRI as Second-line Chemotherapy in Advanced Gastric Cancer
The Korean Journal of Gastroenterology. 2015;66(1):1   Crossref logo
Link1 Link2 Link3

A randomised phase II study of modified FOLFIRI.3 vs modified FOLFOX as second-line therapy in patients with gemcitabine-refractory advanced pancreatic cancer
British Journal of Cancer. 2009;101(10):1658-1663   Crossref logo
Link1 Link2 Link3

Second-line chemotherapy for patients with advanced gastric cancer
Gastric Cancer. 2017;20(3):395-406   Crossref logo
Link1 Link2 Link3

Modified epirubicin and oxaliplatin plus capecitabine (EOX) Regimen as second-line therapy after failure of modified docetaxel and cisplatin plus fuorouracil (DCF) regimen in advanced gastric cancer
Annals of Oncology. 2017;28:v233-v234   Crossref logo
Link1 Link2 Link3

A phase II study of modified FOLFOX as first-line chemotherapy for metastatic gastric cancer in elderly patients with associated diseases
Gastric Cancer. 2012;16(3):411-419   Crossref logo
Link1 Link2 Link3

A Retrospective Study of the Safety and Efficacy of a First-Line Treatment with Modified FOLFOX-4 in Unresectable Advanced or Recurrent Gastric Cancer Patients
Chemotherapy. 2012;58(5):411-418   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.